Study of ALXN1850 in Participants With Hypophosphatasia (HPP)
Clinical trial NCT04980248 · COMPLETED
Trial details
- NCT number
- NCT04980248
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2022-08-24
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.